Medication Assisted Treatment for Opiate Addiction

Medication Assisted Treatment for Opiate Addiction



Centers for Disease Control and Prevention fact sheet on Methadone Maintenance Treatment published in 2002.

National Institutes of Health Consensus Development Conference Statement on Effective Medical Treatment of Opiate Addiction, originally published November 1997.

The American Association for the Treatment of Opioid Dependence’s fact sheet on opioid use, dependence, and treatment

This is a direct link to the State Regulations for Opiate Treatment Programs.

This is a direct link to the Federal Regulations for Opiate Treatment Programs.

CSAT's Division of Pharmacologic Therapies (DPT) manages the day-to-day regulatory oversight activities necessary to implement new SAMHSA regulations (42 CFR Part 8) on the use of Opioid agonist medications (methadone and LAAM) approved by the Food and Drug Administration (FDA) for addiction treatment. These activities include supporting the certification and accreditation of over 1,000 Opioid treatment programs that collectively treat over 200,000 patients annually.
DPT also supports the training of medical and substance abuse professionals on a variety of treatment issues, including the use of new medications, such as Buprenorphine, that are anticipated to be approved by FDA for use by physicians.

The American Association for the Treatment of Opioid Dependence (AATOD) was founded in 1984 to enhance the quality of patient care in treatment programs by promoting the growth and development of comprehensive methadone treatment services throughout the United States.

The National Alliance of Advocates for Buprenorphine Treatment (NAABT)is a non-profit organization with the mission to educate the public about the disease of opioid addiction and the buprenorphine treatment option, to help reduce the stigma and discrimination associated with patients with addiction disorders, and

serve as a conduit connecting patients in need of treatment to qualified treatment providers.

Reckitt Benckiser Pharmaceuticals Inc. official site for Suboxone, providing information on how this medication works, the treatment process, and client stories.

This website features extensive resources, such as: current and past issues of AT Forum newsletters, special research reports, FAQs, regularly updated news, notices of upcoming events, and much more. Although many treatment options and healthcare topics of concern are regularly discussed, an important focus is on methadone maintenance for opioid-addiction treatment.

This 125-page book from Santa Clara Valley Health & Hospital System, San Jose, CA, covers all the basics for clinic staff, patients, community leaders, criminal justice system authorities, and interested others. Presents easy to follow and authoritative information. Newly revised in November 2006.